previous compound ID: 2669 next compound
InChIKey: YBJHBAHKTGYVGT-ZKWXMUAHSA-N
SMILES: C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)O)NC(=O)N2

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "JW Hanrahan" "GW Carlile" "B Kus" "J Goepp" "R Robert" "E Matthes" "D Rotin" "SD Macknight" "DY Thomas"

chemical graph of compound 2669





CID is 171548
synonyms found at PubChem are:
biotin, d-biotin, vitamin H, 58-85-5, coenzyme R, Vitamin B7, Bios II, Factor S, Bioepiderm, D(+)-Biotin, Biodermatin, Medebiotin, Biotinum, Biotine, Meribin, Factor S (vitamin), Injacom H, Lutavit H2, Biotina, (+)-Biotin, beta-Biotin, Vitamin Bw, 3H-Biotin, NSC 63865, CCRIS 3932, HSDB 346, Biotine [INN-French], Biotinum [INN-Latin], Biotina [INN-Spanish], Biotin Forte, 1swk, 1swn, 1swr, Rovimix H2, Rovimix H 2, D-Biotin Factor S, UNII-6SO6U10H04, cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid, cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid, D-(+)-Biotin, AI3-51198, EINECS 200-399-3, cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid, (+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid, 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid, 1H-Thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS-(3aalpha,4beta,6aalpha))-, 5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanoic acid, 2'-Keto-3,4-imidazolido-2-tetrahydrothiophene-N-valeric acid, CHEBI:15956, 6SO6U10H04, (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno(3,4-d)imidazole-4-valeric acid, 5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid, Hexahydro-2-oxo-1H-thieno(3,4-d)imidazole-4-pentanoic acid, (3aS-(3aalpha,4beta,6aalpha))-, DSSTox_CID_2679, (3aS-(3aalpha,4b,6aalpha))-Hexahydro-2-oxo-1H-thieno(3,4-d)imidaz- ole-4-pentanoic acid, DSSTox_RID_76688, DSSTox_GSID_22679, medobiotin, Deacura, Gabunat, Rombellin, Biokur, Biotin Gelfert, Biotin Hermes, Biotine Roche, Gelfert, Biotin, Biotin ratiopharm, Biotin-ratiopharm, Hermes, Biotin, Roche, Biotine, (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-valeric acid, 1H-Thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS-(3aalpha,4b,6aalpha))-, 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid, Biotin (Vitamin B7), BTN, SMR000112255, D(+)Biotin, 1H-thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS,4S,6aR)-, 22879-79-4, Biotin [USP:INN:JAN], Biotin [USAN:INN:JAN], Biopeiderm, 5-(2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid, d-biotine, delta-Biotin, Vitamin-h, 1avd, 1ndj, 1stp, 1swg, 1swp, 2avi, 4bcs, 4ggz, 4jnj, 1H-Thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS,4S,6aR)-, Bioepiderm (TN), CAS-58-85-5, Bios H, NCGC00094984-04, 1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, [3as-(3aalpha,4beta,6aalpha)]-, Biotin111In, delta-(+)-Biotin, Biotin (8CI), delta-biotin factor s, 1df8, 1n9m, 2gh7, 3t2w, 4bj8, Prestwick0_000418, Prestwick1_000418, Prestwick2_000418, Prestwick3_000418, cid_253, BDBM12, bmse000227, CHEMBL857, D0P8TJ, Probes2_000006, AC1L57PN, SCHEMBL8763, BSPBio_000376, Biotin (JP17/USP/INN), MLS001066402, MLS001074888, MLS001331736, MLS001333089, D-Biotin, analytical standard, SPBio_002315, BPBio1_000414, cid_171548, GTPL4787, 5-((4S)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid, DTXSID7022679, BIB0603, 1n43, 2f01, Biotin, >=99.0% (T), MolPort-002-507-373, YBJHBAHKTGYVGT-ZKWXMUAHSA-N, ZX-AFC000477, HMS1569C18, HMS2096C18, HMS2271O06, HMS3713C18, BB_NC-01320, HY-B0511, Tox21_113050, Tox21_302161, BBL028095, Biotin, tested according to Ph.Eur., GV4685, MFCD00005541, s3130, STK801941, ZINC35024346, AKOS001287669, Tox21_113050_1, CCG-220418, CS-2719, DB00121, EBD2202242, LS-3171, MCULE-7440963355, RP28663, Biotin, meets USP testing specifications, Biotin, SAJ special grade, >=98.0%, NCGC00179580-01, NCGC00179580-02, NCGC00179580-04, NCGC00255377-01, 56846-45-8, AC-19998, AJ-45752, BP-20441, BR-44010, CC-35623, KB-49599, SC-18448, ST055761, AB0068872, AX8021635, Biotin, >=99% (TLC), lyophilized powder, Biotin, Vetec(TM) reagent grade, >=99%, TL8003761, AB00374191, B0463, FT-0601580, ST24024711, 58B855, C00120, D00029, M02926, S-1412, AB00374191-08, AB00374191_11, Biotin, plant cell culture tested, >=99% (TLC), C-14824, SR-01000765521, Biotin, certified reference material, TraceCERT(R), Q-200929, SR-01000765521-2, BRD-K89210380-001-03-8, BRD-K89210380-001-13-7, 6AE43AA3-BC3D-4C49-9DB9-5913A2401EB6, Biotin, European Pharmacopoeia (EP) Reference Standard, F2173-0855, Hexahydro-2-oxo-1H-thieno(3,4-d)imidazole-4-pentanoate, Z210803762, Biotin, United States Pharmacopeia (USP) Reference Standard, cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valerate, (+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valerate, 5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate, Daunorubicin hydrochloride, Antibiotic for Culture Media Use Only, (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-valerate, Biotin, Pharmaceutical Secondary Standard; Certified Reference Material, 1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS,4S,6aR)- (9CI), 5-((3aR,6S,6aS)-2-Oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoic acid, 5-[(3aR,6S,6aS)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-6-yl]pentanoic acid, hexahydro-2-oxo-[3aS-(3aa,4b,6aa)]-1H-Thieno[3,4-d]imidazole-4-pentanoate, hexahydro-2-oxo-[3aS-(3aa,4b,6aa)]-1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-[3as-(3alpha,4beta,6alpha)]-1H-Thieno[3,4-d]imidazole-4-pentanoate, hexahydro-2-oxo-[3as-(3alpha,4beta,6alpha)]-1H-Thieno[3,4-d]imidazole-4-pentanoic acid, 15720-24-8, 3672-05-7, 58073-87-3, BIOTIN, PharmaGrade, USP, meets FCC testing specifications, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production., Biotin, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, >=99%